Stakeholder group | Participants (n) | Outcome type | Items retained at end of round 1a, n (%) | Discordant items (%) | ||||
---|---|---|---|---|---|---|---|---|
PRO first | PRO last | Retained by both groups | Retained by PRO first only | Retained by PRO last only | Retained by neither group | |||
Patients | 59 | 57 | PRO | 14/38 | 0/38 | 16/38 | 8/38 | 42.1 |
 |  | Clinical | 28/30 | 2/30 | 0/30 | 0/30 | 13.3 | |
Health professionals | 40 | 31 | PRO | 5/38 | 7/38 | 2/38 | 24/38 | 23.7 |
 |  | Clinical | 12/30 | 10/30 | 1/30 | 7/30 | 36.7 | |
Allb | 99 | 88 | PRO | 17/38 | 1/38 | 13/38 | 7/38 | 36.8 |
 |  | Clinical | 28/30 | 2/30 | 0/30 | 0/30 | 6.7 |